NASDAQ:CTNM | Profit Breakdown | Contineum Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$17.43M-$15.15M
2026-03-31-$16.9M-$14.46M
2025-12-31-$17.12M-$15.16M
2025-09-30-$14.93M-$12.79M
2025-06-30-$17.9M-$16.04M
2025-03-31-$18.11M-$15.99M
2024-12-31$0.00-$17.05M-$14.57M-$14.57M
2024-09-30$0.00-$12.97M-$10.27M-$10.27M
2024-06-30$0.00-$10.94M-$9.01M-$9.01M
2024-03-31-$9.93M-$8.42M-$8.42M
2023-12-31$0.00-$9.68M-$7.93M-$7.77M
2023-09-30$0.00-$8.07M-$6.37M-$6.25M
2023-06-30$50M$38.94M$42.29M$41.56M
2023-03-31-$5.12M-$4.82M-$4.82M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$68.06M-$60.14M-$59.98M
2024-12-31$0.00-$50.89M-$42.26M-$42.26M
2023-12-31$50M$16.08M$23.17M$22.72M